Ionis Pharmaceuticals price to sales ratio IONS

Market value divided by revenue over the last twelve months, since 2011.

Today, Oct 23, 2026: 8.2×
10-year median: 9.7×
Against its 10-year history: 36th; percentile: 0 is its lowest day, 100 its highest
10-year range: 5.4× to 27.2×
Peer median: 7.8×

Ionis Pharmaceuticals' price to sales ratio is 8.2× as of Oct 23, 2026.

That is below its ten-year median of 9.7×, close to the middle of its last ten years.

Over that time it ranged from 5.4× in Mar 2020 to 27.2× in Dec 2016.

The median for 10 large drugmakers of a similar size is 7.8×.

Price to sales ratio over time

median 9.7×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	8.2×	8.2×	14.5×
2025	13.4×	6.1×	13.9×
2024	7.1×	6.7×	12.5×
2023	11.8×	6.3×	12.0×
2022	6.1×	5.6×	7.8×
2021	6.5×	5.6×	10.5×
2020	8.5×	5.4×	10.7×
2019	10.4×	9.5×	19.6×
2018	12.2×	9.7×	13.8×
2017	12.7×	12.0×	24.5×
2016	24.4×	10.2×	27.2×
2015	23.5×	16.6×	49.8×
2014	43.8×	20.6×	54.8×
2013	37.3×	9.6×	39.2×
2012	8.9×	6.9×	13.3×
2011	7.7×	6.6×	9.3×

Against its peers

Companies in Drug Manufacturers - General nearest Ionis Pharmaceuticals' size, closest first, today.

Company	Price to sales ratio
IONSIonis Pharmaceuticals	8.2×
ALKSAlkermes plc.	4.4×
AMRXAmneal Pharmaceuticals	2.1×
TGTXTG Therapeutics	10.4×
LGNDLigand Pharmaceuticals	20.8×
KNSAKiniksa Pharmaceuticals International	7.1×
PTGXProtagonist Therapeutics	31.8×
CORTCorcept Therapeutics	11.2×
BMRNBiomarin Pharmaceutical	3.2×
INDVIndivior Pharmaceuticals	3.1×
ARQTArcutis Biotherapeutics	8.5×
Peer median	7.8×

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Ionis Pharmaceuticals

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.